FDA to examine reports of deaths, heart problems among ADHD drug patients

Share this article:
An FDA study found that 25 people died suddenly and 54 others suffered serious unexplained heart problems while taking attention deficit hyperactivity disorder (ADHD) drugs like Novartis' Ritalin from 1999 to 2003, according to news reports published today. An FDA advisory committee was scheduled to meet Thursday to discuss the data and recommend ways to research whether the drugs are to blame for the deaths. In 2004, approximately 29 million prescriptions were written for Ritalin, Shire's Adderall and similar drugs. Reports of 20 sudden deaths, 12 among children, prompted Canadian health officials to halt sales of Adderall XR last February. After studying the issue, Canadian authorities allowed the drug back on the market in August.
Share this article:

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.